Lemaitre Vascular (LMAT) Accumulated Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Accumulated Expenses data on file, last reported at $3.4 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $3.4 million, down 82.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (down 82.86% YoY), and the FY2025 annual result was $29.4 million, up 18.92% from the prior year.
• Accumulated Expenses declined to $3.4 million in Q1 2026 per LMAT's latest filing, from $29.4 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $29.4 million in Q4 2025 and troughed at $719000.0 in Q3 2025.
• A 5-year average of $12.0 million and a median of $9.9 million in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 634.35% in 2022, then tumbled 96.94% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $20.0 million in 2022, then slumped by 43.67% to $11.2 million in 2023, then jumped by 119.88% to $24.7 million in 2024, then advanced by 18.92% to $29.4 million in 2025, then sank by 88.39% to $3.4 million in 2026.
• Business Quant data shows LMAT's Accumulated Expenses at $3.4 million in Q1 2026, $29.4 million in Q4 2025, and $719000.0 in Q3 2025.